IL62449A - Gonadotropin-release inhibiting peptides and salts thereof and pharmaceutical compositions containing them - Google Patents

Gonadotropin-release inhibiting peptides and salts thereof and pharmaceutical compositions containing them

Info

Publication number
IL62449A
IL62449A IL62449A IL6244981A IL62449A IL 62449 A IL62449 A IL 62449A IL 62449 A IL62449 A IL 62449A IL 6244981 A IL6244981 A IL 6244981A IL 62449 A IL62449 A IL 62449A
Authority
IL
Israel
Prior art keywords
gonadotropin
salts
pharmaceutical compositions
compositions containing
release inhibiting
Prior art date
Application number
IL62449A
Other languages
English (en)
Other versions
IL62449A0 (en
Original Assignee
Salk Inst For Biological Studi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/140,487 external-priority patent/US4292313A/en
Priority claimed from US06/147,555 external-priority patent/US4307083A/en
Application filed by Salk Inst For Biological Studi filed Critical Salk Inst For Biological Studi
Publication of IL62449A0 publication Critical patent/IL62449A0/xx
Publication of IL62449A publication Critical patent/IL62449A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/16—Oxytocins; Vasopressins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/23—Luteinising hormone-releasing hormone [LHRH]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/13—Luteinizing hormone-releasing hormone; related peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
IL62449A 1980-04-15 1981-03-20 Gonadotropin-release inhibiting peptides and salts thereof and pharmaceutical compositions containing them IL62449A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US06/140,487 US4292313A (en) 1980-04-15 1980-04-15 LRF Antagonists
US06/147,555 US4307083A (en) 1978-10-16 1980-05-08 LRF Antagonists
US18259480A 1980-08-29 1980-08-29

Publications (2)

Publication Number Publication Date
IL62449A0 IL62449A0 (en) 1981-05-20
IL62449A true IL62449A (en) 1984-03-30

Family

ID=27385503

Family Applications (1)

Application Number Title Priority Date Filing Date
IL62449A IL62449A (en) 1980-04-15 1981-03-20 Gonadotropin-release inhibiting peptides and salts thereof and pharmaceutical compositions containing them

Country Status (12)

Country Link
EP (1) EP0038135B1 (fr)
KR (1) KR850001159B1 (fr)
AU (1) AU543921B2 (fr)
DD (1) DD160534A5 (fr)
DE (1) DE3164661D1 (fr)
DK (1) DK150206C (fr)
ES (1) ES501321A0 (fr)
GR (1) GR74501B (fr)
IE (1) IE51068B1 (fr)
IL (1) IL62449A (fr)
NZ (1) NZ196558A (fr)
YU (1) YU98981A (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4409208A (en) * 1980-04-15 1983-10-11 The Salk Institute For Biological Studies GnRH antagonists
IL70888A0 (en) * 1983-03-10 1984-05-31 Salk Inst For Biological Studi Gn rh antagonist peptides and pharmaceutical compositions containing them
US4547370A (en) * 1983-11-29 1985-10-15 The Salk Institute For Biological Studies GnRH Antagonists
IL74827A (en) * 1984-05-21 1989-06-30 Salk Inst For Biological Studi Peptides active as gnrh antagonists and pharmaceutical compositions containing them
US4866160A (en) * 1985-04-09 1989-09-12 The Administrators Of The Tulane Educational Fund Therapeutic decapeptides
ZA862570B (en) * 1985-04-09 1986-12-30 Univ Tulane Therapeutic decapeptides
US5084443A (en) * 1989-12-04 1992-01-28 Biomeasure, Inc. Promoting expression of acetylcholine receptors with lhrh antagonist

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1532211A (en) * 1974-10-25 1978-11-15 Wellcome Found Lh-rh peptide analogues
US4087416A (en) * 1976-11-05 1978-05-02 Parke, Davis & Company New heptapeptides and methods for their production
NZ188987A (en) * 1977-11-30 1982-02-23 Salk Inst For Biological Studi Peptide analogues of luteinizing hormone releasing factor

Also Published As

Publication number Publication date
KR830005114A (ko) 1983-07-23
DD160534A5 (de) 1983-09-07
GR74501B (fr) 1984-06-28
EP0038135A2 (fr) 1981-10-21
AU543921B2 (en) 1985-05-09
IL62449A0 (en) 1981-05-20
ES8207510A1 (es) 1982-09-16
DK150206C (da) 1987-07-06
AU6881481A (en) 1981-10-22
YU98981A (en) 1984-04-30
EP0038135B1 (fr) 1984-07-11
DK150206B (da) 1987-01-05
IE810703L (en) 1981-10-15
DK166581A (da) 1981-10-16
DE3164661D1 (de) 1984-08-16
KR850001159B1 (ko) 1985-08-16
NZ196558A (en) 1984-10-19
IE51068B1 (en) 1986-09-17
ES501321A0 (es) 1982-09-16
EP0038135A3 (en) 1982-01-06

Similar Documents

Publication Publication Date Title
IL72799A0 (en) Peptides and pharmaceutical compositions containing them
SG6885G (en) 2-hydroxy-5-phenylazobenzoic acid derivatives and pharmaceutical compositions containing them
ZA813465B (en) Pharmaceutical composition
IL62401A (en) Amino and diamino-pyridines and their salts,their preparation and pharmaceutical compositions containing some of them
IL70365A0 (en) Substituted tetrapeptides,their manufacture and pharmaceutical compositions containing them
DE3168067D1 (en) 2-guanidino-4-heteroarylthiazoles and pharmaceutical compositions containing them
IL61930A (en) 25-hydroxy-26,26,26,27,27,27-hexafluorocholecalciferol and pharmaceutical compositions containing it
DE3165444D1 (en) C-beta-d-xylopyranoside series compounds and pharmaceutical compositions containing them
GB2088373B (en) Dibenzazepine derivatives and pharmaceutical compositions containing them
ZA81136B (en) Pharmaceutical compositions
PH21599A (en) Phenylalkylamines and pharmaceutical compositions containing them
NZ198862A (en) Enkephalin derivatives and pharmaceutical compositions
IL64054A0 (en) Imidazolylpyridines and pharmaceutical compositions containing them
GB2072504B (en) Pharmaceutical compositions
GB2077100B (en) Pharmaceutical compositions containing cromoglycates
IL62449A (en) Gonadotropin-release inhibiting peptides and salts thereof and pharmaceutical compositions containing them
ZA815700B (en) Pharmaceutical compositions
IL70379A (en) Spiro-oxazolidones,-thiazolidones and-imidazolidones and pharmaceutical compositions containing them
GB2132085B (en) Pharmaceutical composition containing l-carnitine
IL68668A0 (en) Piperidinoquinazolines and pharmaceutical compositions containing them
EP0051962A3 (en) Pharmaceutical composition comprising 4-carbamoyl-imidazolium-5-oleate
PT73952B (en) Pharmaceutical compositions
IL62146A0 (en) Guanylamidines and pharmaceutical compositions containing them
ZA814056B (en) Pharmaceutical bicyclo-octatriene compounds and compositions
GB2080301B (en) Substituted pyrimidin-2-ones the salts thereof processes for their preparation and pharmaceutical compositions containing them